The role of the CXCL12/CXCR4/CXCR7 chemokine axis in cancer

Y Shi, DJ Riese, J Shen - Frontiers in pharmacology, 2020 - frontiersin.org
Chemokines are a family of small, secreted cytokines which regulate a variety of cell
functions. The CXC motif chemokine ligand 12 (CXCL12) binds to CXC chemokine receptor …

[HTML][HTML] Cancer stem cell surface markers on normal stem cells

WT Kim, CJ Ryu - BMB reports, 2017 - ncbi.nlm.nih.gov
The cancer stem cell (CSC) hypothesis has captured the attention of many scientists. It is
believed that elimination of CSCs could possibly eradicate the whole cancer. CSC surface …

Cancer stem cells: advances in knowledge and implications for cancer therapy

X Chu, W Tian, J Ning, G Xiao, Y Zhou… - … and Targeted Therapy, 2024 - nature.com
Cancer stem cells (CSCs), a small subset of cells in tumors that are characterized by self-
renewal and continuous proliferation, lead to tumorigenesis, metastasis, and maintain tumor …

Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies

O Saatci, KT Huynh-Dam, O Sahin - Journal of Molecular Medicine, 2021 - Springer
Abstract Estrogen receptor-positive (ER+) breast cancer accounts for approximately 75% of
all breast cancers. Endocrine therapies, including selective ER modulators (SERMs) …

Hypoxia‐inducing factors as master regulators of stemness properties and altered metabolism of cancer‐and metastasis‐initiating cells

M Mimeault, SK Batra - Journal of cellular and molecular …, 2013 - Wiley Online Library
Accumulating lines of experimental evidence have revealed that hypoxia‐inducible factors,
HIF‐1α and HIF‐2α, are key regulators of the adaptation of cancer‐and metastasis‐initiating …

Breast cancer stem cells as drivers of tumor chemoresistance, dormancy and relapse: new challenges and therapeutic opportunities

ML De Angelis, F Francescangeli, A Zeuner - Cancers, 2019 - mdpi.com
Breast cancer is the most frequent cancer among women worldwide. Therapeutic strategies
to prevent or treat metastatic disease are still inadequate although great progress has been …

Emerging targets in cancer management: role of the CXCL12/CXCR4 axis

M Cojoc, C Peitzsch, F Trautmann… - OncoTargets and …, 2013 - Taylor & Francis
The chemokine CXCL12 (SDF-1) and its cell surface receptor CXCR4 were first identified as
regulators of lymphocyte trafficking to the bone marrow. Soon after, the CXCL12/CXCR4 …

Beyond cell motility: the expanding roles of chemokines and their receptors in malignancy

D Morein, N Erlichman, A Ben-Baruch - Frontiers in immunology, 2020 - frontiersin.org
The anti-tumor activities of some members of the chemokine family are often overcome by
the functions of many chemokines that are strongly and causatively linked with increased …

[HTML][HTML] The role of chemokine receptor CXCR4 in breast cancer metastasis

D Mukherjee, J Zhao - American journal of cancer research, 2013 - ncbi.nlm.nih.gov
Breast cancer is one of the leading causes of cancer related deaths worldwide. Breast
cancer-related mortality is associated with the development of metastatic potential of primary …

The breast cancer stem cells traits and drug resistance

Q Zheng, M Zhang, F Zhou, L Zhang… - Frontiers in …, 2021 - frontiersin.org
Drug resistance is a major challenge in breast cancer (BC) treatment at present.
Accumulating studies indicate that breast cancer stem cells (BCSCs) are responsible for the …